000			01722na a2200229 4500
003			H12O
005			20180417112802.0
008			130622s2011 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_9539 _aRuilope Urioste, Luis Miguel _eNefrología
245	0	0	_aRenal function and target organ damage in hypertension _h[artículo]
260			_bEuropean Heart Journal, _c2011.
300			_a32(13):1599-1604.
500			_aFormato Vancouver: Ruilope LM, Bakris GL. Renal function and target organ damage in hypertension. Eur Heart J. 2011 Jul;32(13):1599-604.
501			_aPMID: 21444366
504			_aContiene 47 referencias
520			_aChronic kidney disease (CKD) is frequently observed in patients with arterial hypertension. The same factors that promote the appearance and progression of atherosclerosis can also promote the development of CKD. Two parameters are usually measured to estimate alterations in renal function, the presence of albuminuria, and the estimation of glomerular filtration rate (GFR). Microalbuminuria and a decreased estimated GFR (<60 mL/min/1.73 m(2)) are both accompanied by a significant increase in cardiovascular (CV) risk. Chronic kidney disease can develop all over the cardiorenal continuum and its presence in hypertensive patients with already developed CV disease contributes to a further increase in the development of events and death. Renal protection will in turn obtain CV protection and the treatment to be used is similar to that employed to prevent or to treat established CV disease.
710			_986 _aServicio de Nefrología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/9/pc9732.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c9732 _d9732